Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -27.90x is 116% below its 5-year average of -12.92x, around the middle of its 5-year range (-642.00x–983.39x).
As of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -27.90x.
INTEREST COVERAGE RATIO
-27.90x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-222.71x
INTEREST COVERAGE RATIO AVG 5Y
-12.92x
INTEREST COVERAGE RATIO AVG 10Y
146.50x
INTEREST COVERAGE RATIO AVG 15Y
120.25x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+87.47%
CURRENT VS 5Y AVG
-115.96%
CURRENT VS 10Y AVG
-119.04%
CURRENT VS 15Y AVG
-123.20%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 454 covered companies
CURRENT VS SECTOR MEDIAN
-394.61%
vs the sector median at left
GlucoTrack, Inc.
Market Cap
$873967.00
Interest Coverage Ratio
-27.90x
TTM Avg
N/A
3Y Avg
-222.71x
5Y Avg
-12.92x
Market Cap
$858810.00
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$859930.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$845829.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$821563.00
Interest Coverage Ratio
-8287.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$809925.00
Interest Coverage Ratio
-27.82x
TTM Avg
196.24x
3Y Avg
196.24x
5Y Avg
196.24x
Market Cap
$1.04M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$667373.00
Interest Coverage Ratio
-115.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.07M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GlucoTrack, Inc. (GCTK) | $873967.00 | -27.90x | N/A | -222.71x | -12.92x |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | N/A | 1.00x | 1.00x | 1.00x |
| Bone Biologics Corporation (BBLG)vs › | $859930.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $821563.00 | -8287.21x | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | -27.82x | 196.24x | 196.24x | 196.24x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | -2.27x | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $667373.00 | -115.23x | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | -290.08x | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -7.46x | 10.39x | 21.90x | 21.90x |
Interest Coverage
-27.9x
Debt/Equity
N/A
Current Ratio
0.46
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -27.90x |
| 2024-09-30 | 1.76x |
| 2023-03-31 | -642.00x |
| 2022-06-30 | -280.75x |
| 2021-03-31 | -112.00x |
| 2020-12-31 | 983.39x |
| 2020-09-30 | -0.09x |
| 2020-03-31 | -6247.93x |
| 2019-09-30 | -129.98x |
| 2019-06-30 | -126.73x |
| 2019-03-31 | 219.83x |
| 2018-12-31 | 157.13x |
| 2018-09-30 | 290.24x |
| 2018-06-30 | -650.12x |
| 2018-03-31 | 593.85x |
| 2017-12-31 | 538.11x |
| 2017-09-30 | 462.27x |
| 2017-06-30 | 332.26x |
| 2017-03-31 | 454.71x |
| 2016-12-31 | 484.49x |
| 2016-09-30 | 302.53x |
| 2016-06-30 | 257.51x |
| 2016-03-31 | 521.19x |
| 2015-12-31 | -260.12x |
| 2015-09-30 | 1323.30x |
| 2015-06-30 | 189.39x |
| 2015-03-31 | 340.04x |
| 2014-12-31 | 4.34x |
| 2014-09-30 | -13.59x |
| 2014-06-30 | 0.14x |
| 2014-03-31 | 5.90x |
| 2013-12-31 | 2.20x |
| 2013-09-30 | 26.42x |
| 2013-06-30 | 3.26x |
| 2013-03-31 | 1.05x |
| 2012-12-31 | 49.52x |
| 2012-09-30 | 47.21x |
| 2012-06-30 | 45.38x |
| 2012-03-31 | 49.66x |
| 2011-12-31 | -439.23x |
| 2011-09-30 | 82.75x |
| 2011-06-30 | 24.93x |
| 2011-03-31 | 471.67x |
